Frequency of Metabolic Syndrome on Diabetes Mellitus Patients in Surabaya

Dyah Peni Puspitasari, Budi Widodo, Jongky Hendro Prayitno

Abstract views = 350 times | downloads = 410 times


Introduction: Metabolic syndrome is a syndrome characterized by central obesity, high blood glucose or impaired glucose tolerance, dyslipidemia, and high blood pressure. Nearly 70% to 80% of Diabetes melitus (DM) population was diagnosed with metabolic syndrome. We aimed to present the data of frequency of metabolic syndrome in patients with DM for a basis of future research.

Methods: This is a descriptive study design on DM patients based on NCEP ATP III criteria. The data was collected from direct measurements and laboratory results of all DM patients: waist circumference, weight, height, and blood pressure of the subjects, triglyceride status (TG), high-density lipoprotein cholesterol (HDL-C) status, and fasting blood glucose status.

Results: From 77 DM patients, results were obtained in this study were 69 (89.61%) patients with DM-metabolic syndrome  (DM-MetS) and 8 (10.39%) patients with DM-non-metabolic syndrome. From 69 patients with DM-MetS, 52 (75.36%) were female and 17 (24.64%) were male.

Conclusion: A total of 69 (89.61%) patients with T2DM were diagnosed as metabolic syndrome.


Metabolic syndrome; Diabetes mellitus; NCEP ATP III; Central obesity; Hypertension; Low HDL level; Hypertriglicerides

Full Text:



Haffner SM. The Metabolic Syndrome: Inf lammation, Diabetes Mellitus, and Cardiovascular Disease. The American Journal of Cardiology. 2006;97:suppl 3A-11A.

Dwipayani M, Pande, al e. Prevalensi Sindroma Metabolik pada Populasi Penduduk Bali, Indonesia. Jurnal Penyakit Dalam. 2011;12(1).

Eckel RH. Horrison’s Principles of Internal Medicine. Anthony S. Fauci EB, Dennis L. Kasper, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo, editor. United States2008.

Raman R, Gupta A, Pal SS, Ganesan S, Venkatesh K, Kulothungan V, et al. Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 14). Diabetol Metab Syndr. 2010;2:67.

Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C, National Heart L, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arteriosclerosis, thrombosis, and vascular biology. 2004;24(2):e13-8.

Illiana PP, al e. Prevalence of Metabolic Syndrome and Its Components. Diabetes Care. 2004;27:2135-40.

Widodo B. Asosiasi Prediktif Antara Sindroma Metabolik dengan Kekakuan Arteri Pada Penderita Diabetes Melitus Tipe 2. Surabaya: Universitas Airlangga Rumah Sakit Dokter Soetomo 2008.

Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Kishi R. Metabolic syndrome, C-reactive protein and increased arterial stiffness in Japanese subjects. Hypertension research : official journal of the Japanese Society of Hypertension. 2006;29(8):589-96.

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-9.

Pranoto A, al e. Metabolic Syndrome as Obeserved in Surabaya. Surabaya Metabolic Syndrome Update-12005.

Shanty LM. Asosiasi Sindroma Metabolik dengan Makroangiopati Pada Populasi Diabetes Melitus Tipe 2. Surabaya: Universitas Airlangga; 2007.


  • There are currently no refbacks.

Copyright (c) 2018 Dyah Peni Puspitasari, Budi Widodo, Jongky Hendro Prayitno

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



Creative Commons License

This Journal (E-ISSN:2620-8636) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

View BHSJ Stats